---
figid: PMC8679799__JEM_20211405_Fig1
figtitle: 'Human NLRP1: From the shadows to center stage'
organisms:
- Human immunodeficiency virus 1
- Salmonella enterica subsp. enterica serovar Typhimurium
- Bacillus anthracis
- Shigella flexneri
- Semliki Forest virus
- Tobacco etch virus
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
- Toxoplasma gondii
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Danio rerio
- Mus musculus
- Drosophila melanogaster
pmcid: PMC8679799
filename: JEM_20211405_Fig1.jpg
figlink: /pmc/articles/PMC8679799/figure/fig1/
number: F1
caption: NLRP1 inflammasome activation and its downstream signaling pathway. (A) Overview
  of the domain structure of human NLRP1 and mouse NLRP1B. (B) Overview of human NLRP1
  activation by the DPP8/9 inhibitor VbP. (1) Generation of NLRP1A and NLRP1B by homeostatic
  degradation and assembly of the ternary DPP9-NLRP1A-NLRP1B complex. (2) Direct displacement
  of NLRP1B from the DPP9 substrate tunnel leads to release of the C-terminal UPA-CARD
  fragments and (3) generation of an inflammasome seed. (4) Via the adaptor ASC, caspase-1
  is activated. (5) Caspase-1 cleaves its substrates pro–IL-1β, which matures to pro-inflammatory
  IL-1β, and GSDMD, which (6) generates pores into the membrane and leads to a pyroptotic
  cell death.
papertitle: 'Human NLRP1: From the shadows to center stage.'
reftext: Stefan Bauernfried, et al. J Exp Med. 2022 Jan 3;219(1):e20211405.
year: '2022'
doi: 10.1084/jem.20211405
journal_title: The Journal of Experimental Medicine
journal_nlm_ta: J Exp Med
publisher_name: Rockefeller University Press
keywords: ''
automl_pathway: 0.8012669
figid_alias: PMC8679799__F1
figtype: Figure
redirect_from: /figures/PMC8679799__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8679799__JEM_20211405_Fig1.html
  '@type': Dataset
  description: NLRP1 inflammasome activation and its downstream signaling pathway.
    (A) Overview of the domain structure of human NLRP1 and mouse NLRP1B. (B) Overview
    of human NLRP1 activation by the DPP8/9 inhibitor VbP. (1) Generation of NLRP1A
    and NLRP1B by homeostatic degradation and assembly of the ternary DPP9-NLRP1A-NLRP1B
    complex. (2) Direct displacement of NLRP1B from the DPP9 substrate tunnel leads
    to release of the C-terminal UPA-CARD fragments and (3) generation of an inflammasome
    seed. (4) Via the adaptor ASC, caspase-1 is activated. (5) Caspase-1 cleaves its
    substrates pro–IL-1β, which matures to pro-inflammatory IL-1β, and GSDMD, which
    (6) generates pores into the membrane and leads to a pyroptotic cell death.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NLRP1
  - PLAU
  - PRAP1
  - GSDMD
  - IL1B
  - DPP9
  - STS
  - PYCARD
  - Nlrp1a
  - Nlrp1b
  - Prap1
  - Gsdmd
  - Il1b
  - Dpp9
  - Pycard
  - nlrp1
  - nlrc7
  - nlrp16
  - nlrc6
  - nlrc8
  - carmil1
  - il1b
  - dpp9
  - pycard
  - Plau
  - pyd
  - LRR
  - ww
  - upd1
  - ac
  - ase
  - AstC
---
